TC-99M TETROFOSMIN REST STRESS MYOCARDIAL SPET WITH A SAME-DAY 2-HOURPROTOCOL - COMPARISON WITH CORONARY ANGIOGRAPHY - A SPANISH-PORTUGUESE MULTICENTER CLINICAL-TRIAL/
R. Montz et al., TC-99M TETROFOSMIN REST STRESS MYOCARDIAL SPET WITH A SAME-DAY 2-HOURPROTOCOL - COMPARISON WITH CORONARY ANGIOGRAPHY - A SPANISH-PORTUGUESE MULTICENTER CLINICAL-TRIAL/, European journal of nuclear medicine, 23(6), 1996, pp. 639-647
Technetium-99m tetrofosmin (Myoview) has unique properties for myocard
ial perfusion imaging very early after injection of the tracer. We use
d a very short same-day rest/stress protocol, to be performed within 2
h and evaluated its diagnostic accuracy. The study included 144 patie
nts from seven Spanish and four Portuguese centres with a diagnosis of
uncomplicated coronary artery disease (CAD); 78 patients (54%) had no
history of prior myocardial infarction, Patients were injected with l
ess than or equal to 300 MBq Tc-99m-tetrofosmin at rest and less than
or equal to 900 MBq approximately 1 h later at peak exercise, Single-p
hoton emission tomographic (SPET) acquisitions were initiated within 5
-30 min post injection. The results were compared with those of corona
ry angiography (CA). The data of 142 patients were completely evaluabl
e (two with non-evaluable images were excluded). The quality of rest i
mages was excellent or good in 86%, regionally problematic in 7%, poor
but well interpretable in 5% and non-evaluable in 2%. The overall sen
sitivity for the detection of CAD was 93%, the specificity 38% and the
accuracy 85%, The localization of defects by SPET in relation to the
perfusion territories of stenosed vessels (greater than or equal to 50
%) was achieved with a sensitivity of 64% for the left anterior descen
ding artery, 49% for the left circumflex artery and 86% for the right
coronary artery, and an accuracy of 71%, 72% and 73% respectively. Con
cordance of SPET and CA was 62% for single-vessel dis ease and 68% for
multivessel disease. In conclusion, this Spanish-Portuguese multicent
re clinical trial confirmed, in a considerable number of patients who
underwent coronary angiography, the feasibility of Tc-99m tetrofosmin
(Myoview) rest/stress myocardial SPET using a very short protocol (2 h
).